The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
prostate cancer screening is is really quite poor I mean really it's like kind of a it's a it's almost like just you know um nonrandomly assigning people to get prostate biopsies right as you getting PSA tests basically it's it's it's not a great way of detecting um Cancers and certainly not potentially dangerous prostate cancers
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.